Notice of Application to Register a Trade Name Product (Notice No. MPI ACVM 45)
Notice is given under section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997 (“Act”), of the following application to register a trade name product under section 9(1) of the Act:
Trade Name: Zenalpha Injection for Dogs
Reference: A012035
Active Ingredients and Concentrations:
10mg/mL Vatinoxan hydrochloride (equivalent to 9.2mg/mL Vatinoxan) and 0.5mg/mL medetomidine hydrochloride (equivalent to 0.425mg/mL medetomidine)
Formulation Type: Aqueous solution
Application method/administration route:
Intramuscular injection at 1mg of medetomidine hydrochloride and 20mg of vatinoxan hydrochloride (equivalent to 2mL of solution) per square meter of body surface area.
Use Claim:
A sedative and analgesic in dogs to facilitate clinical examinations, clinical procedures, and minor surgical procedures
Any person may make a written submission to the director-general concerning this application.
Under sections 16 and 17 of the Act, a written submission:
Each submission must state the trade name product(s) to which it relates. Under section 18 of the Act, a copy of every submission will be forwarded to the applicant.
The following address is:
ACVM Team, Ministry for Primary Industries, Charles Fergusson Building, 38–42 Bowen Street, Pipitea, Wellington 6011. Postal Address: PO Box 2526, Wellington 6140. Email: acvm.consultation@mpi.govt.nz.
MPI encourages submission by email.
The applicant’s address for service is:
Dechra Veterinary Products NZ Limited, 198A Kapiti Road, Paraparaumu 5032. Postal Address: 2 Cal Close, Somersby, New South Wales 2250, Australia.
Dated at Wellington this 13th day of November 2024.
SHALEEN NARAYAN, Manager Approvals, Ministry for Primary Industries (acting under delegated authority).